U
EXEL icon

UBS’s Exelixis EXEL Stock Holding History

UBS’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$107K Buy
69,772
+1,070
+2% +$3.43K ﹤0.01% 5916
2014
Q2 		$233K Buy
68,702
+13,275
+24% +$45.8K ﹤0.01% 4992
2014
Q1 		$196K Buy
55,427
+27,125
+96% +$185K ﹤0.01% 5214
2013
Q4 		$173K Sell
28,302
-1,500
-5% -$8.27K ﹤0.01% 5463
2013
Q3 		$173K Sell
29,802
-23,498
-44% -$122K ﹤0.01% 5365
2013
Q2 		$242K Buy
+53,300
New +$253K ﹤0.01% 4890

Other funds holding EXEL

MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS's EXEL Position: Q3 2014 in Review

UBS increased its Exelixis (EXEL) stake by 1.6% in Q3 2014, buying an estimated $3.43K and bringing the position to 69,772 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #5916.

UBS first reported a position in EXEL in Q2 2013 and has held it in 6 quarters since. The position peaked at $242K in Q2 2013. 125 funds tracked by Wall St. Rank hold EXEL as of Q3 2014.

  • UBS held 69,772 shares of Exelixis worth $107K as of Q3 2014.
  • UBS bought 1,070 Exelixis shares in Q3 2014, an estimated $3.43K.
  • Exelixis made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5916 holding.
  • UBS first reported a position in Exelixis in Q2 2013 and has held it in 6 quarters since.
  • UBS's Exelixis position peaked at $242K in Q2 2013.
  • 125 funds tracked by Wall St. Rank held Exelixis as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.